Related Image: Lifeclinic to Showcase Health Stations and Health Communicator at the National Association of Chain Drug Stores 2009 Pharmacy and Technology Conference |
(Date:11/24/2009)...an recruiting firm LocumTenens.com, a leading prov...o announce its agreement with VHA Inc., a national...um tenens assignments. , ...cian recruiting firm LocumTenens.com , a leading...sed to announce its agreement with VHA Inc., a nat...
(Date:11/24/2009)...ewswire-USNewswire/--GovernorEdwardG.Rendelltodaya...fluwerevaccinatedduringtheweekendatpublichealthcli...tments. ,, "Withthefederalgovernmentunabletopro...ilabilityofH1N1vaccine,distributionhasbeenchalleng...theH1N1vaccinedistributionprocessinPennsylvania.Ho...
(Date:11/24/2009)...24/PRNewswire/--Nextmonth,UnitedHealthcarewilloffe...panic-AmericanseniorsunderstandthebasicsofMedicare...eeZumba®Goldclass,aLatin-infusedfitnessprogra...,andtango. ,, UnitedHealthcarewillofferthesesem...gedwhenlearningabouttheirhealthcareoptions. There...
(Date:11/24/2009)...Newswire-FirstCall/--HealthSouthCorporation(NYSE: ...ricaMerrillLynch2009CreditConferenceinNewYorkonDec...TreasurerEdFaywillbespeakingonThursday,Dec.3,2009,...llbeavailableat http://investor.healthsouth.com by... ,, HealthSouthisthenation,slargestproviderofi...
(Date:11/24/2009)...s heart prospects, but cancer risk remains , ...study offers yet more proof that smoking is a majo...cer. , Researchers followed 12,152 American and... and nonsmokers for three years. During that time,...e of cancer, 2.26 times more likely to die of hear...
Breaking Medicine News(10 mins):Health News:VHA Names LocumTenens.com as Preferred Physician Staffing Vendor 2Health News:Governor Rendell Announces 100,000 At-Risk Pennsylvanians Vaccinated at H1N1 Public Health Clinics; Addresses Future Vaccine Distribution Plans 2Health News:UnitedHealthcare To Offer Seniors Hispanic-Centered Medicare Education Seminars Combined With a Latin-Themed Fitness Program 2Health News:Smokers Double Their Risk for Heart Disease 2...as 50% through the consumption of non-fat milk pro...f Navarra researchers. The American Journal of Cli...esearch. The study evaluated the connection betwee...an elevated consumption of skimmed milk and milk p...
... intensified its drive against tobacco consumption...ready employed by the WHO // at its Geneva headqua... though they will also be encouraged to quit smoki...will give up smoking if they were to be employed b...
...sity Baptist Medical Center shows that patient tru...f a law to legalize physician-assisted // death we...y is based on the results of a telephonic survey c...ts were required to rate their level of agreement ...
...tnessing an alarming increase in the number of HIV.../cases, while the number of HIV cases has gone bey...n HIV cases in 2004 was at 0.5%, in the State, whi...on HIV/AIDS patients. West Bengal is witnessing a ...
...s sought to be overhauled by the Government in its...tising of the food // and drinks industry will be ...from being targeted at children.
The health ...tritional problems, starting from hospitals to sch...
...on Rajabrata Sarkar, MD, PhD, at the San Francisco...nism that helps in the growth of new arteries // .... key factor for the development of new arteries es...equence of the MMP2 gene, which encodes an enzyme ...
Other Medicine News:Health News:Identification Of Gene Sequence To Promote Growth Of New Arteries 2(Date:11/24/2009)....,Nov.24/PRNewswire/--Inadditiontofamily,friendsan...lphiajurorstoherThanksgivinggratitudelist. ,, "...ltothem,"shesaidofMonday,sverdictstotaling$103mill...neskiisamong12,000womennationwidewhohavesuedWyetha...rugsPremarinandPrempro.Wisneskiandtheothervictimso...
(Date:11/24/2009)...C.,Nov.24/PRNewswire/--PharmaceuticalInstitute,ale...harmaceuticalandbiotechindustry,todayannouncedthel...enew HospitalMarketplace e-courseisthenewestadditi...es,acomprehensiveseriesofe-coursesdesignedtofillth...ledgeforcommercialprofessionals. ,, Thenewthree...
(Date:11/24/2009)...,Nov.24/PRNewswire-USNewswire/--America,spharmaceu...medicinesandvaccinestotreatorpreventHIV/AIDSandrel...ythePharmaceuticalResearchandManufacturersofAmeric...IDSDay"-aglobalawarenesscampaignthatoriginatedatth...AIDSPrevention. ,, "Wearegreatlyencouragedbythe...
Breaking Medicine Technology:Maryland Woman Thankful for Wyeth Verdicts 2Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace 2New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 2New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 3President Clinton and Mylan Chairman and CEO Robert J Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug Resistant HIV i 53873 1President Clinton and Mylan Chairman and CEO Robert J Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug Resistant HIV i 53873 2President Clinton and Mylan Chairman and CEO Robert J Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug Resistant HIV i 53873 3President Clinton and Mylan Chairman and CEO Robert J Coury Announce New Agreement to Lower Price of Treatment for Patients with Drug Resistant HIV i 53873 4Live recordings of cell communication 53872 1Live recordings of cell communication 53872 2Does Facebook usage contribute to jealousy in relationships 3F 53869 1Does Facebook usage contribute to jealousy in relationships 3F 53869 2...s. and ORLANDO, Fla., March 29 Boston,Scientific ...ar results from the,SPIRIT II Clinical Trial and a...IRIT II and III Trials. SPIRIT II and SPIRIT III ... with 300 and 1,002 patients respectively,designed...R) (XIENCE V(TM)),Everolimus-Eluting Coronary Sten...
...T II Trial, XIENCE V Drug Eluting Stent Demonstrat...XUS in Key Safety Endpoints, Including an 88 Perce... Years , , ORLANDO, Fla., March 29 Long-term dat...IRIT II clinical trial demonstrated that the clini...ng Coronary Stent System continued to increase bet...
Other Medicine Technology:Clinical Data Reinforce Safety and Efficacy of Boston Scientific's Two Drug- Eluting Stent Platforms 2Clinical Data Reinforce Safety and Efficacy of Boston Scientific's Two Drug- Eluting Stent Platforms 3Clinical Data Reinforce Safety and Efficacy of Boston Scientific's Two Drug- Eluting Stent Platforms 4Clinical Data Reinforce Safety and Efficacy of Boston Scientific's Two Drug- Eluting Stent Platforms 5Abbott's Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years 2Abbott's Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years 3Abbott's Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years 4Abbott's Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years 5...UHTS), Analyst GT delivers unsurpassed multimode a...sfer of assays into screening from assay developme...yst AD and HT, fluorescence intensity, fluorescenc...scence, absorbance, as well as providing seamless ...
...Analyst HT smoothes the transfer of assays into HT...y performance of Analyst AD, fluorescence intensit...cence, luminescence, absorbance. Optimized for se...uding those from Beckman Coulter, Zymark, CRS and ...
...lopment and basic research, including a simple ins...ime required to move assays into HTS. Specifically...ment laboratories, Analyst AD delivers unparallele..., Fluorescence Polarization, Time-Resolved Fluores...
...oplate based multi-detection reader which incorpor...orescence Polarization , Fluorescence Intensity ,...minescence (flash and glow) , Absorbance ,It i...dioactive labeled applications:, , Ca2+ Measuremen...
Medicine Products: